- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.04. | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | 12 | The Motley Fool | ||
| 17.04. | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.03. | Peeling Back The Layers: Exploring AdaptHealth Through Analyst Insights | 2 | Benzinga.com | ||
| 27.02. | AdaptHealth Corp. - 10-K, Annual Report | 3 | SEC Filings | ||
| 27.02. | Why AdaptHealth Stock Is Skyrocketing Today | 4 | The Motley Fool | ||
| 27.02. | AdaptHealth posts Q4 loss, revenue climbs | 3 | Investing.com | ||
| 27.02. | AdaptHealth Corp. Q4 Loss increases, misses estimates | - | RTTNews | ||
| 27.02. | AdaptHealth GAAP EPS of -$1.91 misses by $2.07, revenue of $858.2M beats by $32.75M | 2 | Seeking Alpha | ||
| 27.02. | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.02. | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | 238 | Business Wire | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| 26.02. | AdaptHealth Q4 2023 Earnings Preview | 1 | Seeking Alpha | ||
| 29.01. | In-Depth Examination Of 4 Analyst Recommendations For AdaptHealth | 1 | Benzinga.com | ||
| 27.12.23 | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.12.23 | AdaptHealth Corp. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 22.11.23 | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.11.23 | AdaptHealth Corp. (AHCO) Q3 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 08.11.23 | Earnings call: AdaptHealth reports Q3 2023 earnings, records $804M revenue amid growth in sleep and respiratory product lines | 1 | Investing.com | ||
| 07.11.23 | AdaptHealth Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.11.23 | AdaptHealth slides on downbeat annual core profit forecast | 1 | Reuters | ||
| 07.11.23 | Why AdaptHealth Stock Trading Is Lower Today | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 27,210 | +0,11 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
| ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler: Kurssprung nach Vorab-Zahlen … was ist das wert? | Am Montagnachmittag wartete der Strahlentechnik-Spezialist Eckert & Ziegler mit vorläufigen Ergebnissen zum 1. Quartal auf. Die Aktie machte einen Satz nach oben ... wie lässt sich das charttechnisch... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,900 | +4,07 % | Hims & Hers Health, Inc. - 8-K, Current Report | ||
| ORPEA | 12,582 | +5,11 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 346,00 | 0,00 % | Limes Schlosskliniken erwartet Zuwachs bei Umsatz und EBITDA | Die Kölner Limes Schlosskliniken AG meldet für 2023 einen Anstieg der Gesamterträge um 26 Prozent auf 37,4 Millionen Euro. Vor Zinsen und Steuern sinkt der Gewinn um 22 Prozent auf 4,7 Millionen Euro... ► Artikel lesen | |
| FULGENT GENETICS | 18,700 | 0,00 % | Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| NANO-X IMAGING | 9,030 | +1,23 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| LANTHEUS | 61,00 | +0,33 % | Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings | ||
| RADNET | 45,000 | -1,32 % | RadNet, Inc. Announces Date of its First Quarter 2024 Financial Results Conference Call | ||
| BUTTERFLY NETWORK | 0,773 | +9,56 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| MEDISTIM | 15,000 | 0,00 % | Dividendenbekanntmachungen (25.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALBERTSONS COMPANIES INC US0130911037 0,12 USD 0,1121 EUR ASSA ABLOY AB SE0007100581 2,7 SEK 0,2318 EUR ASSA ABLOY AB ADR US0453871073 0... ► Artikel lesen | |
| HAEMONETICS | 80,50 | 0,00 % | Haemonetics Corporation: Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge | BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes... ► Artikel lesen | |
| GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,110 | +0,25 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
| CARMAT | 3,150 | -3,08 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen |
ADAPTHEALTH CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 9,860 Euro und damit +2,92 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
